Cargando…

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly

INTRODUCTION: The clinical significance of ventriculomegaly in cognitively normal elderly individuals remains unclear. METHODS: We selected cognitively normal individuals (n = 425) from the Alzheimer's Disease Neuroimaging Initiative database and calculated Evans index (EI) based on the ratio o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaofeng, Ba, Maowen, Ng, Kok Pin, Mathotaarachchi, Sulantha, Pascoal, Tharick A., Rosa-Neto, Pedro, Gauthier, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678356/ https://www.ncbi.nlm.nih.gov/pubmed/29159265 http://dx.doi.org/10.1016/j.dadm.2017.08.001

Ejemplares similares

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment
por: Pascoal, Tharick A., et al.
Publicado: (2020)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
por: Ba, Maowen, et al.
Publicado: (2016)

Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates
por: Schoemaker, Dorothee, et al.
Publicado: (2017)

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
por: Therriault, Joseph, et al.
Publicado: (2018)

Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [(18)F]THK5351 uptake in progressive supranuclear palsy
por: Ng, Kok Pin, et al.
Publicado: (2019)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
por: Gauthier, Serge, et al.
Publicado: (2018)

VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
por: Mathotaarachchi, Sulantha, et al.
Publicado: (2016)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
por: Ng, Kok Pin, et al.
Publicado: (2017)

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2018)

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Impact of long- and short-range fibre depletion on the cognitive deficits of fronto-temporal dementia
por: Savard, Melissa, et al.
Publicado: (2022)

In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240
por: Pascoal, Tharick A., et al.
Publicado: (2018)

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem
por: Benedet, Andréa L., et al.
Publicado: (2018)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
por: Tissot, Cécile, et al.
Publicado: (2021)

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
por: Benedet, Andréa L., et al.
Publicado: (2019)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images
por: Sharafi, Sayed Mehran, et al.
Publicado: (2019)

Wilson's disease: MRI features
por: Singh, Paramdeep, et al.
Publicado: (2011)

Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
por: Wang, Yi-Ting T, et al.
Publicado: (2021)

Automatic measure and normalization of spinal cord cross-sectional area using the pontomedullary junction
por: Bédard, Sandrine, et al.
Publicado: (2022)

Optimizing automated white matter hyperintensity segmentation in individuals with stroke
por: Ferris, Jennifer K., et al.
Publicado: (2023)

An Anisotropic 4D Filtering Approach to Recover Brain Activation From Paradigm-Free Functional MRI Data
por: Costantini, Isa, et al.
Publicado: (2022)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Unique features of polycythemia observed on plain non contrast CT scan of head
por: Gayathri, S., et al.
Publicado: (2010)

A Riemannian Revisiting of Structure–Function Mapping Based on Eigenmodes
por: Deslauriers-Gauthier, Samuel, et al.
Publicado: (2022)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
por: Collij, Lyduine E., et al.
Publicado: (2021)

Structural and functional characterization of the locus coeruleus in young and late middle-aged individuals
por: Berger, Alexandre, et al.
Publicado: (2023)

Epistasis analysis links immune cascades and cerebral amyloidosis
por: Benedet, Andréa L., et al.
Publicado: (2015)

Association of plasma P-tau181 with memory decline in non-demented adults
por: Therriault, Joseph, et al.
Publicado: (2021)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Structural Brain Imaging Predicts Individual-Level Task Activation Maps Using Deep Learning
por: Ellis, David G., et al.
Publicado: (2022)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Reduced future-oriented decision making in individuals with subjective cognitive decline: A functional MRI study
por: Hu, Xiaochen, et al.
Publicado: (2017)

Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features
por: Low, Audrey, et al.
Publicado: (2019)

Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode network
por: Rane, Swati, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_00r57112d9d57rapa36rs2as2o